It is named a focused therapy since it exclusively targets the CD38 which can be overexpressed on the multiple myeloma cells. Daratumumab is from a class of medicines named CD38 monoclonal antibodies. Overview the entire individual medication manual and discuss this information and any issues you might have with your https://bonog111jai3.losblogos.com/profile